This is the authors' abstract. We don't add key points for this paper.
Cascade reactions efficiently generate molecular complexity but are often incompatible with the late-stage diversification of highly functionalized natural products due to competing degradation pathways. Herein, we demonstrate that electrophilic fluorination can serve as a variable control element, selectively capturing transient nucleophiles to install fragment-deactivating C–F bonds that redirect subsequent reactivity away from default degradation. In a derivative of the antibiotic salinomycin, sequential fluorination events gate a multistep structural cascade, converting a single precursor into diverse, unprecedented scaffolds. Stepwise reagent selection enables divergent cascade routing through enol ether manifolds to achieve controlled scaffold remodeling. These results demonstrate late-stage electrophilic fluorination as a switchable fragment-deactivation strategy for directing complex cascade transformations and unlocking new natural product architectures.
No takes yet. Share an insight, caveat, or question.
Ruskin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: